Encephalitis Induced by Immune Checkpoint Inhibitors-Reference-Cited by-同舟云学术

Encephalitis Induced by Immune Checkpoint Inhibitors

Published:2021-07-01 Issue:7 Volume:78 Page:864
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Velasco Roser¹²,Villagrán Macarena³⁴,Jové Maria⁵,Simó Marta¹,Vilariño Noelia¹⁵,Alemany Montserrat¹,Palmero Ramon⁵,Martínez-Villacampa Maria Mercedes⁶,Nadal Ernest⁵,Bruna Jordi¹²

Affiliation:

1. Neuro-Oncology Unit, Hospital Universitari de Bellvitge-Institut Català d Oncologia L’Hospitalet, Institut d´Investigació Biomèdica de Bellvitge, l’Hospitalet de Llobregat, Barcelona, Spain

2. Institute of Neurosciences and Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Bellaterra, Spain

3. Neurology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain

4. Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla, Sevilla, Spain

5. Thoracic Oncology Unit, Institut Català d Oncologia L’Hospitalet, Institut d´Investigació Biomèdica de Bellvitge, L’Hospitalet, Barcelona, Spain

6. Department of Medical Oncology, Institut Català d Oncologia L’Hospitalet, Institut d´Investigació Biomèdica de Bellvitge, L’Hospitalet, Barcelona, Spain

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2777621/jamaneurology_velasco_2021_rv_210001_1624467410.9432.pdf

Reference57 articles.

1. Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: experience beyond the clinical trials.;Bruna;J Peripher Nerv Syst,2020

2. Risk of neurological toxicities following the use of different immune checkpoint inhibitor regimens in solid tumors: a systematic review and meta-analysis.;Xu;Neurologist,2019

3. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors.;Graus;Nat Rev Clin Oncol,2019

4. Value of onconeural antibodies in checkpoint inhibitor–related toxicities.;Vogrig;Ann Neurol,2020

5. Central nervous system complications associated with immune checkpoint inhibitors.;Vogrig;J Neurol Neurosurg Psychiatry,2020

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor–induced CNS inflammation;eBioMedicine;2024-02

2. Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes;The Lancet Neurology;2024-01

3. DPPX-Antibody-Associated Encephalitis Induced by Immune Checkpoint Inhibitor Treatment for Advanced Hepatocellular Carcinoma;Journal of Clinical Neurology;2024

4. Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management;Pharmaceutical Medicine;2024-01

5. Exploring a Rarity: Incidence of and Therapeutic Approaches for Neurological Complications and Hypophysitis in Cancer Patients on Immune Checkpoint Inhibitors—A Single-Center Study;Current Oncology;2023-12-18